EPISODE · Jan 29, 2025 · 3 MIN
Getting Down to Business - January 29, 2025
from Getting Down to Business · host Getting Down to Business
In this episode of Getting Down to Business, host Kadie DiGiuseppe goes over: - Novo Nordisk's Ozempic being approved to treat kidney disease in people with Type 2 diabetes. - Starbucks looking to make a comeback after its fiscal year results were announced. - 23andMe announcing it will be exploring alternatives after the company has faced a decline in sales.
What this episode covers
In this episode of Getting Down to Business, host Kadie DiGiuseppe goes over: - Novo Nordisk's Ozempic being approved to treat kidney disease in people with Type 2 diabetes. - Starbucks looking to make a comeback after its fiscal year results were announced. - 23andMe announcing it will be exploring alternatives after the company has faced a decline in sales.
NOW PLAYING
Getting Down to Business - January 29, 2025
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.